Selection and testing of the suitability of antigens for neurodegeneration diagnostics (Q10677)

From EU Knowledge Graph
Revision as of 07:11, 22 October 2020 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in 1 language: translated_label)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Selection and testing of the suitability of antigens for neurodegeneration diagnostics
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    189,000.0 Czech koruna
    0 references
    7,560.0 Euro
    10 January 2020
    0 references
    252,000.0 Czech koruna
    0 references
    10,080.0 Euro
    10 January 2020
    0 references
    75 percent
    0 references
    8 March 2017
    0 references
    31 December 2017
    0 references
    31 December 2017
    0 references
    VIDIA spol. s r.o.
    0 references
    0 references

    49°59'0.49"N, 14°30'9.11"E
    0 references
    25250
    0 references
    V rámci projektu bude proveden výběr a charakterizace antigenů pro diagnostiku neurodegenerativních onemocnění, jednak s ohledem na jejich komerční dostupnost, popř. možnou vlastní přípravu, na stav práv duševního vlastnictví a jednak s ohledem na jejich předpokládané využití pro diferenciální diagnostiku zamýšlených onemocnění. Vybrané antigeny budou dále ověřeny na panelech reálných vzorků se známou diagnózou. a. (Czech)
    0 references
    The project will provide for the selection and characterisation of antigens for the diagnosis of neurodegenerative diseases and, on the other hand, their commercial availability, possibly their own preparation, the status of intellectual property rights and their intended use for differential diagnosis of the intended diseases. The selected antigens will be further verified on real sample panels with known diagnosis. (English)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_045/0009746
    0 references